Results 221 to 230 of about 171,246 (253)

Identification of the molecular basis of doxorubicin-induced cardiotoxicity

Nature Medicine, 2012
Tasneem Bawa-Khalfe, Leroy F Liu
exaly  

Doxorubicin

Reactions Weekly, 2020
  +4 more sources

Late Cardiac Effects of Doxorubicin Therapy for Acute Lymphoblastic Leukemia in Childhood

New England Journal of Medicine, 1991
Stephen P Sanders
exaly  

Carfilzomib/doxorubicin/doxorubicin liposomal

Reactions Weekly, 2015
openaire   +1 more source

Doxorubicin

Reactions Weekly, 2023
openaire   +2 more sources

Omission of doxorubicin from the treatment of stage II–III, intermediate-risk Wilms' tumour (SIOP WT 2001): an open-label, non-inferiority, randomised controlled trial

Lancet, The, 2015
Kathryn Pritchard-Jones, christophe Bergeron, Beatriz de Camargo   +2 more
exaly  

Doxorubicin

Reactions Weekly, 2021
openaire   +1 more source

Mitochondrial Determinants of Doxorubicin-Induced Cardiomyopathy

Circulation Research, 2020
Kendall B Wallace, Paulo J Oliveira
exaly  

Doxorubicin liposomal, Doxorubicin pegylated liposomal

2010
Ines Mader, Patrizia Fürst-Weger, Robert Mader, Elisabeth Nogler-Semenitz, Sabine Wassertheurer   +4 more
openaire   +1 more source

Doxorubicin see Daunorubicin/doxorubicin

Reactions Weekly, 1990
openaire   +1 more source